Related references
Note: Only part of the references are listed.Serum endocan concentration and its correlation with severity of hypertensive disorders in pregnancy
Agata Szpera-Gozdziewicz et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2020)
Metabolic syndrome and pre-eclampsia
M. C. E. Hooijschuur et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2019)
Endocan expression in placenta of women with hypertension
Bee S. Chew et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2019)
First trimester placental endothelial cells from pregnancies with abnormal uterine artery Doppler are more sensitive to apoptotic stimuli
Nicoletta Charolidi et al.
LABORATORY INVESTIGATION (2019)
Histological Features of Shallow Placental Implantation Unify Early-Onset and Late-Onset Preeclampsia
Jerzy Stanek
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2019)
Adolescent Preeclampsia: Pathological Drivers and Clinical Prevention
Ivo Brosens et al.
REPRODUCTIVE SCIENCES (2019)
Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/PlGF Ratio in Singleton Pregnancies
Ignacio Herraiz et al.
FETAL DIAGNOSIS AND THERAPY (2018)
Changes in endothelial cell specific molecule 1 plasma levels during preeclamptic pregnancies compared to healthy pregnancies
Joost H. N. Schuitemaker et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2018)
Preeclampsia biomarkers: An assessment of maternal cardiometabolic health
Genevieve Eastabrook et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2018)
Afamin: an early predictor of preeclampsia
Angela Koeninger et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
Pro-angiogenic therapeutics for preeclampsia
Adrian C. Eddy et al.
BIOLOGY OF SEX DIFFERENCES (2018)
Negative Correlation between Placental Growth Factor and Endocan-1 in Women with Preeclampsia
Marta Ribeiro Hentschke et al.
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA (2018)
Obesity and cardiovascular diseases
Sergey Kachur et al.
MINERVA MEDICA (2017)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Michael A. Gimbrone et al.
CIRCULATION RESEARCH (2016)
Endocan and Endothelial Dysfunction
Mustafa Aparci et al.
ANGIOLOGY (2015)
Serum endocan concentration in women with pre-eclampsia
Mehmet Aytac Yuksel et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes
Henry Adekola et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2015)
Endocan-A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension: A Pilot Study
Sevket Balta et al.
ANGIOLOGY (2014)
Birth weight for gestational age: A reference study in a tertiary referral hospital in the middle region of Turkey
Hasan Onur Topcu et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2014)
Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A-Induced Angiogenesis
Filip Roudnicky et al.
CANCER RESEARCH (2013)
Preeclampsia, a Disease of the Maternal Endothelium The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease
Camille E. Powe et al.
CIRCULATION (2011)
Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy
S Sarrazin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2006)
Share Paper
